Philip D Coblentz
Overview
Explore the profile of Philip D Coblentz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
46
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Coblentz P, Ahn B, Hayward L, Yoo J, Christou D, Ferreira L
Am J Physiol Lung Cell Mol Physiol
. 2019 Feb;
316(4):L679-L690.
PMID: 30702345
Heart failure with reduced ejection fraction (HFREF) increases neutral sphingomyelinase (NSMase) activity and mitochondrial reactive oxygen species (ROS) emission and causes diaphragm weakness. We tested whether a systemic pharmacological NSMase...
2.
Ahn B, Coblentz P, Beharry A, Patel N, Judge A, Moylan J, et al.
Front Physiol
. 2017 Jan;
7:686.
PMID: 28119629
Patients with heart failure (HF) have diaphragm abnormalities that contribute to disease morbidity and mortality. Studies in animals suggest that reactive oxygen species (ROS) cause diaphragm abnormalities in HF. However,...
3.
Laitano O, Ahn B, Patel N, Coblentz P, Smuder A, Yoo J, et al.
J Appl Physiol (1985)
. 2016 Feb;
120(7):733-42.
PMID: 26846552
Diaphragm muscle weakness in chronic heart failure (CHF) is caused by elevated oxidants and exacerbates breathing abnormalities, exercise intolerance, and dyspnea. However, the specific source of oxidants that cause diaphragm...